BIOMARKERS
Biomarkers for Gastric cancer
1. TP53
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. ERBB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. CEACAM5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. BCL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. AKT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. EGFR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. MYC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. PR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. NR4A3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. MAPK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. CDKN2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. KIT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. Ki-67
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. MLH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. PIK3CA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. ESR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. FGFR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. APC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. ER
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. AFP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. CDH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. SRC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. MS4A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. FBXW7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. ITK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. JUN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. MSH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. MUC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. ROS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. FAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. TIMP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. CTLA4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. STAT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. SERPINE1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. AR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. IL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. CDX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. MTOR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. TG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. KRAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. PTEN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. SDHB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. KDR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. CD79A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. HRAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. MET
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. GNAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. RHOA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. HIF1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. LDH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. CDKN1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. FUS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. RB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. DDIT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. PRF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. SDHA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. MUC16
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. PDGFRA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. FGFR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. BRCA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. BRD4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. uPA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. ATM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. SMAD4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. BRAF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. ERBB3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. POU5F1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. hCG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. MDM2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. SDHD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. SPEN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. ABL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. FHIT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. PTPN11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. FOXP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. MAX
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. PTPRC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. FH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. CYLD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. ABL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. FANCA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. CgA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. IGH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. CXCR4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. BIRC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. BRCA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. CCDC6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. RPL22
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. SMAD3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. CDK4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. CALR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. MALT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. STK11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. SOX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. MSH6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. ABCG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. RHOH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. ARID1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. EZH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. SMAD2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. PRKAR1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. ENO2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. BCR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. CD274
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. ERCC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. TP63
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. HSP90AA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. CCND1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. NKX2-1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. PTCH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. PDCD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. CLIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. JAK2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. RAC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. PSA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. MAP2K1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. NRAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. GOPC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. HLA-A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. ALDH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. MDM4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. CALCB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. CDK6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. NOTCH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. BLM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. TERT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. CTNNB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. RAF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. U2AF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. BCL10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. EP300
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. MEN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. MYCN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. NCKIPSD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. ARID1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. PMS2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. ALK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. CBL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. POLE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. SMO
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. ERBB4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. NTRK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. IL6ST
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. KLF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. HMGA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. NFE2L2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. YWHAE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. Beta-hCG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. KMT2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. NF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. CASP8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. CUX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. DNMT3A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. PDGFRB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. CHEK2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. FLT4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. RARA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. EBF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. STIL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. VHL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. AXIN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. MUTYH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. TCF7L2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. ERCC5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. NBN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. RUNX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. SMARCB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. TGFBR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. CDH11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. NF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. PPFIBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. CEP17
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. ATR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. FGFR3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. TSC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. TOP2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. ERCC4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. PIM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. SDHC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. HER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. AKT2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. PMS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. SALL4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. ELN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. FOXO3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. KLF6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. LMNA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. FGFR4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. FOXO1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. NDRG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. RET
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. BCL6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. CD74
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. DICER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. MYB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. SOCS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. XPC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. CCND2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. ETV4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. FES
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. MALAT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. MAP2K4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. NRG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. PDGFB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. TPR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. CREBBP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. FOXP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. GATA3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. MYD88
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. NOTCH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. NPM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. WT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. BMPR1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. CDKN2C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. DROSHA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. EWSR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. NT5C2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. SH3GL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. TSC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. AXIN2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. BUB1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. CCNE1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. CIC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. COL1A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. FEV
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. IDH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. IDH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. JAK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. KMT2C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. MYOD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. NSD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. PML
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. STAT5B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. TAL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. ETV1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. FAT4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. HLF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. KEAP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. NIN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. PAX5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. PRDM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. RNF43
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. SUFU
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. SYK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. WIF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. Neurokinin
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. CREB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. ETV6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. FLT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. KLK2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. PDCD1LG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. TCF3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. TNFAIP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. TRIM27
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. BTK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. ERG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. ETV5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. FANCC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. GPC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. HEY1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. HOXD13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. MAF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. PAX8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. PLCG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. SMARCA4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. SS18
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. TET1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. TRA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. ARNT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. CDC73
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. DDX5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. DDX6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. HOXA13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. KMT2D
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. MAP3K1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. MYCL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. PCSK7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. POT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. PPM1D
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. REL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. SSX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. SUZ12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. XPA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. CYP2D6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. WFDC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. AMER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. BAP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. BCL3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. ELF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. FOXA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. HERPUD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. HNF1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. IKZF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. IL7R
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. JAK3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. NUTM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. SETD2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. SFRP4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. SND1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. SRSF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. STAT6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. WHSC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. ZNF331
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. ATF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. B2M
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. BCL7A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. COL2A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. DDB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. EML4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. FANCD2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. HNRNPA2B1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. LASP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. MPL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. MYH9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. NONO
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. NTRK3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. PER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. PPARG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. PTPRT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. SETBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. SPECC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. TET2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. TFRC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. TOP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. XPO1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. ACVR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. APOBEC3B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. ARHGEF12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. ATRX
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. BCL9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. BCOR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. CEBPA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. DAXX
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. DDR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. DNAJB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. ERCC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. FAT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. FGFR1OP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. FLCN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. FLI1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. FOXO4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. FUBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. GNAQ
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. HMGA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. HOXA9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. HSP90AB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. IRF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. LEF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. LRP1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. MECOM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. MITF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. MLF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. MSN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. PALB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. PICALM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. PIK3R1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. POU2AF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. PTPN13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. RSPO2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. SEPT5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. SPOP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. UBR5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. WRN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. ZNF198
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. ABI1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. ACVR2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. AFF3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. ARID2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. BRIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. BTG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. CARS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. CD79B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. CIITA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. CLTC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. CNBP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. CTCF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. EXT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. EZR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. FANCF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. HOXC11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. KDM6A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. LIFR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. LMO2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. MED12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. PAX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. PLAG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. PPP2R1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. PRRX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. PTPRB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. SFPQ
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. SLC34A2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. SLC45A3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. SSX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. STAG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. TBX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. TFG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. TMPRSS2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. TNFRSF14
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. TRD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. WAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. AFF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. AKAP9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. ARHGAP26
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. BCL11A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. BCL11B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. CANT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. CARD11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. CBFA2T3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. CBFB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. CCND3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. CDK12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. CNTRL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. CRTC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. DCTN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. DEK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. EPAS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. ETNK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. FANCE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. FCGR2B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. GATA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. GATA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. GRIN2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. HIST1H3B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. HOXA11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. HOXD11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. IGK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. IGL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. IKBKB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. KDM5A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. LCK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. LMO1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. MNX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. MSI2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. MYO5A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. NACA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. NCOR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. NFIB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. NFKBIE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. NUMA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. NUP214
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. NUP98
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. PAX7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. PBRM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. PBX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. PRDM16
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. PREX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. PTK6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. QKI
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. RABEP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. RAD21
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. RAD51B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. RALGDS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. RECQL4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. SEPT6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. SEPT9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. SF3B1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. SMARCD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. SRSF3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. STRN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. TAF15
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. TBL1XR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. TCF12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. TFE3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. TLX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. TNFRSF17
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. TPM3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. TRB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. TRIM24
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. TRRAP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. TSHR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. TTL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. USP6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. WHSC1L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. WWTR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. ZRSR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. CAD-ALK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. CD52
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. SET
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. ACKR3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. ACSL3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. ACSL6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. AFF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. ASPSCR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. ASXL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. ATIC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. ATP1A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. ATP2B3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. BCL5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. BCL9L
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. BCORL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. BRD3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. C12orf9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. C15orf65
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. C2orf44
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. CACNA1D
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. CAMTA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. CASC5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. CBLB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. CBLC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. CCNB1IP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. CEP89
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. CHCHD7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. CHD4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. CHIC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. CLP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. CLTCL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. CNOT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. COX6C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. CREB3L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. CREB3L2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. CRLF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. CRTC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. CSF3R
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. DDX10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. DDX3X
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. DNM2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. DUX4L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. ECT2L
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. EIF3E
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. EIF4A2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. ELK4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. ELL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. EPS15
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. ERC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. EXT2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. FAM131B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. FAM46C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. FANCG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. FBXO11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. FCRL4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. FIP1L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. FNBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. FOXL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. FSTL3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. GAS7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. GMPS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. GNA11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. GOLGA5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. GPHN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. H3F3A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. H3F3B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. HIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. HIST1H4I
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. HMGN2P46
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. HOOK3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. HOXC13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. IL21R
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. JAZF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. KAT6A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. KAT6B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. KCNJ5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. KDM5C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. KDSR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. KIAA1549
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. KIAA1598
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. KIF5B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. KTN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. LCP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. LHFP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. LPP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. LRIG3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. LSM14A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. LYL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. LZTR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. MAFB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. MAML2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. MAP2K2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. MAP3K13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. MDS2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. MKL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. MLLT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. MLLT10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. MLLT11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. MLLT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. MLLT4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. MLLT6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. MN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. MTCP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. MYH11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. NAB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. NCOA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. NCOA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. NCOA4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. NCOR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. NFATC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. NFKB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. NUTM2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. NUTM2B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. OLIG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. OMD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. P2RY8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. PAFAH1B2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. PCM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. PDE4DIP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. PHF6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. PHOX2B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. PPP6C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. PRCC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. PRKACA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. PSIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. PTPRK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. PWWP2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. RANBP17
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. RANBP2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. RAP1GDS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. RBM10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. RBM15
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. RMI2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. RNF213
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. RNF217-AS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. RPL10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. RPL5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. RPN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. RSPO3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. RUNDC2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. RUNX1T1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. SBDS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. SDC4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. SDHAF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. SH2B3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. SMARCE1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. SRGAP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. SS18L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. SSX4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. TAL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. TCEA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. TCL1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. TCL6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. TFEB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. TFPT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. THRAP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. TLX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. TMEM127
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. TPM4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. TRAF7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. TRIM33
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. TRIP11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. USP8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. VTI1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. ZBTB16
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. ZCCHC8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. ZFHX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. ZNF278
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. ZNF384
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. ZNF521
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. Cytokeratin fragment 21-1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. IHC4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. MAP-Tau mRNA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. MK167
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. Nuclear matrix protein 22
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. PAM50
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]